ReviewDrug design, development and therapy2013

Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib.

Hannah V Woodcock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.